Find My Journal

PD

Pierre Delanaye

University of Liège BE

0000-0002-1480-5761

759

Publications

13,588

Citations

60

H-Index

216

i10-Index

3.34

2yr Mean Cite

-

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Percentiles of estimating glomerular filtration rate: a new personalized tool for detection of chronic kidney disease.

P. Delanaye, C. Mariat - Kidney International, 2026

Cited by 0 Semantic Scholar

[Patient with type 2 diabetes and progressive chronic kidney disease].

A. Scheen, P. Delanaye - Revue Medicale de Liege, 2025

Cited by 0 Semantic Scholar

[Biomarkers for an early detection of patients at risk of renal or cardiovascular disease].

A. Scheen, P. Delanaye, F. Jouret, Patrizio Lancellotti, Etienne Cavalier - Revue Medicale de Liege, 2025

Cited by 0 Semantic Scholar

[International guidelines for the assessment of chronic kidney disease].

P. Delanaye, F. Jouret, Etienne Cavalier - Revue Medicale de Liege, 2025

Cited by 0 Semantic Scholar

[Guidelines for the basic management of chronic kidney disease].

P. Delanaye, N. Paquot, F. Jouret, A. Scheen - Revue Medicale de Liege, 2025

Cited by 0 Semantic Scholar

[New outcome studies with injectable semaglutide in different at risk populations].

A. Scheen, P. Delanaye, Patrizio Lancellotti - Revue Medicale de Liege, 2024

Cited by 0 Semantic Scholar

[SGLT2 inhibitors : on the borders of diabetology, cardiology, nephrology and… primary care].

A. Scheen, Patrizio Lancellotti, P. Delanaye, Didier Giet - Revue Medicale de Liege, 2023

Cited by 1 Semantic Scholar

[Finerenone (Kerendia®), a new weapon against the chronic kidney disease of a patient with type 2 diabetes].

A. Scheen, P. Delanaye - Revue Medicale de Liege, 2023

Cited by 0 Semantic Scholar

[Kidney injury in COVID-19].

P. Erpicum, S. Grosch, Antoine Bouquegneau, J. Huart, G. Résimont - Revue Medicale de Liege, 2020

Cited by 14 Semantic Scholar

Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME. OA

A. Scheen, P. Delanaye - Diabetes & Metabolism, 2017

Cited by 42 Semantic Scholar

Research Topics

Chronic Kidney Disease and Diabetes (267) Dialysis and Renal Disease Management (201) Parathyroid Disorders and Treatments (85) Renal Diseases and Glomerulopathies (66) Renal and Vascular Pathologies (53)

Affiliations

Université Paris-Sud

FR 2015 - 2015

University of Padua

IT 2014 - 2014

Innsbruck Medical University

AT 2014 - 2014

Inserm

FR 2015 - 2015

University of Liège

BE 2026 - 1998

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers